S
Stephen B. Liggett
Researcher at University of South Florida
Publications - 296
Citations - 24710
Stephen B. Liggett is an academic researcher from University of South Florida. The author has contributed to research in topics: Receptor & Agonist. The author has an hindex of 80, co-authored 285 publications receiving 23813 citations. Previous affiliations of Stephen B. Liggett include Washington University in St. Louis & University of Miami.
Papers
More filters
Journal ArticleDOI
Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness.
Connie M. Drysdale,Dennis W. McGraw,Catharine B. Stack,J. Claiborne Stephens,Richard S. Judson,Krishnan Nandabalan,Kevin M. Arnold,Gualberto Ruaño,Stephen B. Liggett +8 more
TL;DR: The results indicate that the unique interactions of multiple SNPs within a haplotype ultimately can affect biologic and therapeutic phenotype and that individual SNPs may have poor predictive power as pharmacogenetic loci.
Journal ArticleDOI
Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.
TL;DR: Three naturally occurring polymorphisms of the human beta 2-adrenergic receptor caused by missense mutations encoding for amino acids 16 and 27 of the extracellular N-terminus of the receptor are delineated and the functional consequences of these polymorphisms by site-directed mutagenesis and the recombinant expression of these receptors in Chinese hamster fibroblasts are studied.
Journal ArticleDOI
Transgenic Gαq overexpression induces cardiac contractile failure in mice
Drew D. D'Angelo,Yoshihito Sakata,John N. Lorenz,Gregory P. Boivin,Richard A. Walsh,Stephen B. Liggett,Gerald W. Dorn +6 more
TL;DR: The Gαq overexpressor exhibits a biochemical and physiologic phenotype resembling both the compensated and decompensated phases of human cardiac hypertrophy and suggests a common mechanism for their pathogenesis.
Journal ArticleDOI
Mutations in the Gene Encoding for the β2-adrenergic Receptor in Normal and Asthmatic Subjects
TL;DR: The gene encoding the beta 2AR was examined to assess the frequency of polymorphisms in patients with moderate to severe asthma and normal subjects, and one mutation identified a subset of patients with a distinct clinical profile.
Journal ArticleDOI
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial
Elliot Israel,Vernon M. Chinchilli,Jean G. Ford,Homer A. Boushey,Reuben M. Cherniack,Timothy J. Craig,Aaron Deykin,Joanne K. Fagan,John V. Fahy,James E. Fish,Monica Kraft,Susan J. Kunselman,Stephen C. Lazarus,Robert F. Lemanske,Stephen B. Liggett,Richard J. Martin,Nandita Mitra,Stephen P. Peters,Eric S. Silverman,Christine A. Sorkness,Stanley J. Szefler,Michael E. Wechsler,Scott T. Weiss,Jeffrey M. Drazen +23 more
TL;DR: Genotype at the 16th aminoacid residue of the beta2-adrenergic receptor affects the long-term response to albuterol use and Bronchodilator treatments avoiding albutersol may be appropriate for patients with the Arg/Arg genotype.